Geode Capital Management’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Buy |
903,970
+216,509
| +31% | +$1.1M | ﹤0.01% | 2771 |
|
|
2025
Q1 | $3.89M | Buy |
687,461
+232,037
| +51% | +$1.31M | ﹤0.01% | 2767 |
|
|
2024
Q4 | $3.95M | Buy |
455,424
+6,427
| +1% | +$55.8K | ﹤0.01% | 2855 |
|
|
2024
Q3 | $3.11M | Buy |
448,997
+51,111
| +13% | +$354K | ﹤0.01% | 2970 |
|
|
2024
Q2 | $2.47M | Buy |
397,886
+252,180
| +173% | +$1.56M | ﹤0.01% | 3063 |
|
|
2024
Q1 | $230K | Buy |
145,706
+6,453
| +5% | +$10.2K | ﹤0.01% | 3895 |
|
|
2023
Q4 | $205K | Hold |
139,253
| – | – | ﹤0.01% | 3934 |
|
|
2023
Q3 | $130K | Buy |
139,253
+8,050
| +6% | +$7.49K | ﹤0.01% | 4158 |
|
|
2023
Q2 | $165K | Hold |
131,203
| – | – | ﹤0.01% | 4125 |
|
|
2023
Q1 | $180K | Hold |
131,203
| – | – | ﹤0.01% | 4103 |
|
|
2022
Q4 | $234K | Buy |
131,203
+2,357
| +2% | +$4.2K | ﹤0.01% | 4010 |
|
|
2022
Q3 | $404K | Buy |
128,846
+53,629
| +71% | +$168K | ﹤0.01% | 3838 |
|
|
2022
Q2 | $243K | Hold |
75,217
| – | – | ﹤0.01% | 4145 |
|
|
2022
Q1 | $382K | Buy |
75,217
+16,932
| +29% | +$86K | ﹤0.01% | 4075 |
|
|
2021
Q4 | $455K | Buy |
58,285
+37,890
| +186% | +$296K | ﹤0.01% | 4106 |
|
|
2021
Q3 | $221K | Buy |
+20,395
| New | +$221K | ﹤0.01% | 4410 |
|